Orchestra BioMed CFO has 3,076 shares withheld

Orchestra BioMed Holdings, Inc. (OBIO) reported that Chief Financial Officer Andrew Taylor Lawrence had 3,076 shares of common stock withheld on 2026-08-26 to satisfy tax withholding obligations related to vesting of restricted stock units.

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. (OBIO) reported that Chief Financial Officer Andrew Taylor Lawrence had 3,076 shares of common stock withheld on 2026-08-26 to satisfy tax withholding obligations related to vesting of restricted stock units. The filing states that no shares were sold in the market. Following this tax-withholding transaction, Lawrence directly holds 589,989 shares of OBIO common stock.

Insider Trade Summary

Tax Withholding: 3,076 shares

Tax Withholding 1 txn

Insider Taylor Andrew Lawrence

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock, par value $0.0001 per share F1	3,076	$5.26	$16K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 589,989 shares (Direct)

Footnotes (1)

1. F1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

Key Figures

Shares withheld for taxes: 3,076 shares Per-share value used for withholding: $5.26 per share Shares held after transaction: 589,989 shares

3 metrics

Shares withheld for taxes 3,076 shares Withholding of shares to satisfy tax withholding obligations on 2026-08-26

Per-share value used for withholding $5.26 per share Value applied to the 3,076 withheld shares for tax withholding purposes

Shares held after transaction 589,989 shares Direct OBIO common stock holdings of Andrew Taylor Lawrence following the transaction

Key Terms

restricted stock units ("RSUs"), tax withholding obligations, withholding of shares, payment of tax liability by delivering or withholding securities

4 terms

restricted stock units ("RSUs") financial

"in connection with vesting of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with vesting of restricted stock"

withholding of shares financial

"Represents the withholding of shares by the Issuer to satisfy tax"

payment of tax liability by delivering or withholding securities financial

"transaction code description is Payment of tax liability by delivering or withhold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OBIO CFO Andrew Taylor Lawrence report on this Form 4?

CFO Andrew Taylor Lawrence reported the withholding of 3,076 OBIO shares on 2026-08-26 to satisfy tax withholding obligations arising from vesting of restricted stock units. The filing states that no shares were sold in the market as a result.

How many OBIO shares were withheld for taxes in the latest Form 4?

The Form 4 reports that 3,076 shares of Orchestra BioMed common stock were withheld to cover tax withholding obligations in connection with vesting of restricted stock units, at a reported value of $5.26 per share for this purpose.

Did the OBIO CFO sell any shares in the market in this Form 4 transaction?

No. The footnote explains that the transaction represents withholding of shares by the issuer to satisfy tax withholding obligations upon RSU vesting, and that no shares were sold in the market as a result of this event.

What are Andrew Taylor Lawrence’s OBIO holdings after this Form 4 transaction?

After the tax-withholding transaction, Chief Financial Officer Andrew Taylor Lawrence directly holds 589,989 shares of Orchestra BioMed common stock, as reported in the Form 4’s post-transaction holdings field.

What does transaction code F mean in the OBIO Form 4 filing?

In this OBIO Form 4, transaction code F is described as payment of tax liability by delivering or withholding securities. A footnote clarifies it reflects share withholding to satisfy tax obligations tied to vesting restricted stock units, not an open-market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 04:17 PM EDT Accepted by SEC EDGAR 08/28/2026 - 04:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Andrew Lawrence

(Last) (First) (Middle)

C/O ORCHESTRA BIOMED HOLDINGS, INC.

150 UNION SQUARE DRIVE

(Street)

NEW HOPE PENNSYLVANIA 18938

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	08/26/2026		F(1)		3,076	D	$5.26	589,989	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

	/s/ Andrew Taylor	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)